BioAtla, Inc. (BCAB)
1.26
-0.06
(-4.55%)
USD |
OTCM |
Sep 08, 16:00
BioAtla Total Assets (Quarterly) : 9.506M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.506M |
| March 31, 2026 | 8.566M |
| December 31, 2025 | 14.99M |
| September 30, 2025 | 15.91M |
| June 30, 2025 | 27.13M |
| March 31, 2025 | 38.29M |
| December 31, 2024 | 52.42M |
| September 30, 2024 | 62.24M |
| June 30, 2024 | 68.64M |
| March 31, 2024 | 89.20M |
| December 31, 2023 | 119.66M |
| September 30, 2023 | 151.36M |
| June 30, 2023 | 179.64M |
| March 31, 2023 | 204.55M |
| Date | Value |
|---|---|
| December 31, 2022 | 225.74M |
| September 30, 2022 | 189.11M |
| June 30, 2022 | 213.50M |
| March 31, 2022 | 230.65M |
| December 31, 2021 | 254.42M |
| September 30, 2021 | 277.58M |
| June 30, 2021 | 216.71M |
| March 31, 2021 | 229.09M |
| December 31, 2020 | 244.94M |
| September 30, 2020 | 62.77M |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 9.336M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 14.86M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 45.74M |
| Shareholders Equity (Quarterly) | -36.24M |
| Debt to Equity Ratio | -0.1618 |
| Current Ratio | 0.2026 |
| Net Debt Paydown Yield | -15.42% |